Acute hemodynamic effect of sildenafil in comparison with inhaled nitric oxide in patients receiving bosentan therapy for pulmonary arterial hypertension

被引：0
|
作者：
Galie, Nazzareno [1 ]
Michelakis, Evangelos [1 ]
Vachiery, Jean-Lue [1 ]
Vizza, Carmine Dario [1 ]
Meyer, F. J. [1 ]
Gruenig, Ekkehard [1 ]
机构：
[1] Univ Bologna, Bologna, Italy
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：488S / 488S
页数：1
相关论文
共 50 条
  • [31] Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy
    Porhownik, Nancy R.
    Al-Sharif, Hassan
    Bshouty, Zoheir
    CANADIAN RESPIRATORY JOURNAL, 2008, 15 (08) : 427 - 430
  • [32] Effect of inhaled nitric oxide on exercise pulmonary pressure in patients with pulmonary hypertension
    Kuperstein, R
    Sasson, Z
    Persaud, J
    Granton, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 285A - 286A
  • [33] Acute Hemodynamic Effects of Single-Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS-1 Study
    Gruenig, Ekkehard
    Michelakis, Evangelos
    Vachiery, Jean-Luc
    Vizza, Carmine Dario
    Meyer, F. Joachim
    Doelberg, Martin
    Bach, Doris
    Dingemanse, Jasper
    Galie, Nazzareno
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (11): : 1343 - 1352
  • [34] Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension
    Suntharalingam, J.
    George, P.
    Hughes, R.
    Goldsmith, K.
    Toshner, M.
    Sheares, K.
    Pepke-Zaba, J.
    THORAX, 2006, 61 : II65 - II65
  • [35] First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension
    Lunze, K.
    Gilbert, N.
    Mebus, S.
    Miera, O.
    Fehske, W.
    Uhlemann, F.
    Muehler, E. G.
    Ewert, P.
    Lange, P. E.
    Berger, F.
    Schulze-Neick, I.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 32 - 38
  • [36] Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil
    Mouchaers, K. T. B.
    Schalij, I.
    de Boer, M. A.
    Postmus, P. E.
    van Hinsbergh, V. W. M.
    Amerongen, G. P. van Nieuw
    Noordegraaf, A. Vonk
    van der Laarse, W. J.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (04) : 800 - 807
  • [37] Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil
    Milman, Nils
    Svendsen, Claus Bo
    Iversen, Martin
    Videbaek, Regitze
    Carlsen, Jorn
    CLINICAL RESPIRATORY JOURNAL, 2009, 3 (04): : 207 - 213
  • [38] IS THERE VALUE IN REPEATING INHALED NITRIC OXIDE VASOREACTIVITY TESTS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION?
    Tooba, Rubabin
    Tonelli, Adriano
    Almoushref, Allaa
    CHEST, 2019, 156 (04) : 329A - 329A
  • [39] The effect of inhaled nitric oxide therapy on thromboelastogram in newborns with persistent pulmonary hypertension
    Sema Tanriverdi
    Ozge Altun Koroglu
    Ozgun Uygur
    Can Balkan
    Mehmet Yalaz
    Nilgun Kultursay
    European Journal of Pediatrics, 2014, 173 : 1381 - 1385
  • [40] Is There Value in Repeating Inhaled Nitric Oxide Vasoreactivity Tests in Patients with Pulmonary Arterial Hypertension?
    Tooba, Rubabin
    Almoushref, Allaa
    Tonelli, Adriano R.
    LUNG, 2020, 198 (01) : 87 - 94
12345